Paper41809040
miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma.
Singh G and 18 others. iScience, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma. Papers, record 41809040. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41809040
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References104
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38254819 | The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38254819 | PubMed |
| 2 | 38242327 | MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives. | Biochim Biophys Acta Mol Cell Res | 2024 | https://conductscience.org/library/papers/38242327 | PubMed |
| 3 | 29800684 | MiRNAs: dynamic regulators of immune cell functions in inflammation and cancer. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29800684 | PubMed |
| 4 | 26030228 | MicroRNA regulation of lymphocyte tolerance and autoimmunity. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26030228 | PubMed |
| 5 | 33015624 | Regulation and pharmacological targeting of RAD51 in cancer. | NAR Cancer | 2020 | https://conductscience.org/library/papers/33015624 | PubMed |
| 6 | 28076755 | RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells. | Stem Cell Reports | 2017 | https://conductscience.org/library/papers/28076755 | PubMed |
| 7 | 34316706 | Homologous recombination, cancer and the 'RAD51 paradox'. | NAR Cancer | 2021 | https://conductscience.org/library/papers/34316706 | PubMed |
| 8 | 31455032 | Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges. | Vaccines (Basel) | 2019 | https://conductscience.org/library/papers/31455032 | PubMed |
| 9 | 33000209 | miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/33000209 | PubMed |
| 10 | 28302823 | PARP inhibitors: Synthetic lethality in the clinic. | Science | 2017 | https://conductscience.org/library/papers/28302823 | PubMed |
| 11 | 27317386 | MicroRNA: Small RNA mediators of the brains genomic response to environmental stress. | Prog Neurobiol | 2016 | https://conductscience.org/library/papers/27317386 | PubMed |
| 12 | 24205116 | MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. | PLoS One | 2013 | https://conductscience.org/library/papers/24205116 | PubMed |
| 13 | 33970795 | A qualitative study of experiences of asylum-seeker women of living in detention centres: confinement versus safety. | Contemp Nurse | 2021 | https://conductscience.org/library/papers/33970795 | PubMed |
| 14 | 33433610 | PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/33433610 | PubMed |
| 15 | 34337348 | Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. | Cancer Drug Resist | 2021 | https://conductscience.org/library/papers/34337348 | PubMed |
| 16 | 26159421 | Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26159421 | PubMed |
| 17 | 34036721 | DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies. | Mol Oncol | 2022 | https://conductscience.org/library/papers/34036721 | PubMed |
| 18 | 38982158 | Sensing and guiding cell-state transitions by using genetically encoded endoribonuclease-mediated microRNA sensors. | Nat Biomed Eng | 2024 | https://conductscience.org/library/papers/38982158 | PubMed |
| 19 | 27358111 | Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma. | Mol Cancer Res | 2016 | https://conductscience.org/library/papers/27358111 | PubMed |
| 20 | 35646698 | Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors. | Front Oncol | 2022 | https://conductscience.org/library/papers/35646698 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857251 | A Selective Pro-Oxidant Drives Redox Reprogramming to Induce Ferroptosis and Immune Remodeling in Glioblastoma. | Smart Med | 2026 | https://conductscience.org/library/papers/42857251 | PubMed |
| 42368021 | MicroRNA-181 influences Alzheimer's risk by regulating neprilysin and microtubule-associated tau pathways, offering a novel target. | bioRxiv | 2026 | https://conductscience.org/library/papers/42368021 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41809040
GET https://conductscience.org/api/papers/v1/41809040/references?page=2